Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®
This week Neurocrine Biosciences announced the results of its KINECT®-4 Phase 3 study of INGREZZA® capsules. Results of the trial were published in the Journal of Clinical Psychopharmacology. A long-term…